Drug Therapy Review 2008

Treatment considerations in metastatic breast cancer(MBC) are discussed, beginning with HER2/neu expression and hormone sensitvity.  The efficacy, satety, and dosing of taxanes in the treatment of MBC are reviewed

view PDF